Advertisement
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1. Gruys E, Obwolo MJ, Tousaint JM. Diagnostic significance of the major acute phase proteins in veterinary clinical chemistry: a review. Vet Bull 1994;64:1009–1018.
-
2. Cerón JJ, Eckersall PD, Subiela SM. Acute phase proteins in dogs and cats: current knowledge and future perspectives. Vet Clin Pathol 2005;34:85–99.
-
3. Eckersall PD, Bell R. Acute phase proteins: biomarkers of infection and inflammation in veterinary medicine. Vet J 2010;185:23–27.
-
4. Kjelgaard-Hansen M, Jacobsen S. Assay validation and diagnostic applications of major acute-phase protein testing in companion animals. Clin Lab Med 2011;31:51–70.
-
5. Tecles F, Spiranelli E, Bonfanti U, et al. Preliminary studies of serum acute-phase protein concentrations in hematologic and neoplastic diseases of the dog. J Vet Intern Med 2005;19:865–870.
-
6. Mobasheri A, Cassidy JP. Biomarkers in veterinary medicine: towards targeted, individualised therapies for companion animals. Vet J 2010;185:1–3.
-
7. Paltrinieri S. Early biomarkers of inflammation in dogs and cats: the acute phase proteins. Vet Res Commun 2007;31:125–129.
-
8. Kajikawa T, Furuta A, Onishi T, et al. Changes in concentrations of serum amyloid A protein, alpha-1-acid glycoprotein, haptoglobin and C-reactive protein in feline sera due to induced inflammation and surgery. Vet Immunol Immunopathol 1999;68:91–98.
-
9. Correa SS, Mauldin GN, Mauldin GE, et al. Serum alpha 1-acid glycoprotein concentration in cats with lymphoma. J Am Anim Hosp Assoc 2001;37:153–158.
-
10. Sasaki K, Ma Z, Khatlani S, et al. Evaluation of feline serum amyloid A (SAA) as an inflammatory marker. J Vet Med Sci 2003;65:545–548.
-
11. Duthie S, Eckersall PD, Addie DD, et al. Value of alpha-1 acid glycoprotein in the diagnosis of feline infectious peritonitis. Vet Rec 1997;141:299–303.
-
12. Ganz PA, Shell WE, Tokes ZA. Evaluation of a radioimmunoassay for α1-acid glycoprotein to monitor therapy of cancer patients. J Natl Cancer Inst 1983;71:25–30.
-
13. Selting KA, Ogilvie GK, Lana SE, et al. Serum alpha 1-acid glycoprotein concentrations in healthy and tumor-bearing cats. J Vet Intern Med 2000;14:503–506.
-
14. Giordano A, Spagnolo V, Colombo A, et al. Changes in some acute phase protein and immunoglobulin concentrations in cats affected by feline infectious peritonitis or exposed to feline coronavirus infection. Vet J 2004;167:38–44.
-
15. Vail DM. Moore AS, Ogilvie GK, et al. Feline lymphoma (145 cases): proliferation indices, cluster of differentiation 3 immunoreactivity and their association with prognosis in 90 cats. J Vet Intern Med 1998;12:349–354.
-
16. Ettinger SN. Principles of treatment for feline lymphoma. Clin Tech Small Anim Pract 2003;18:98–102.
-
17. Kann RKC, Seddon JM, Henning J, et al. Acute phase proteins in healthy and sick cats. Res Vet Sci 2012;93:649–654.
-
18. Aziz N, Fahey JL, Detels R, et al. Analytical performance of a highly sensitive C-reactive protein-based immunoassay and the effects of laboratory variables on levels of protein in blood. Clin Diagn Lab Immunol 2003;10:652–657.
-
19. Leal RO, Gil S, Sepulveda N, et al. Monitoring acute phase proteins in retrovirus infected cats undergoing feline interferon-ω therapy. J Small Anim Pract 2014;55:39–45.
-
20. Kuribayashi T, Shimizu M, Shimada T, et al. Alpha-1-acid glycoprotein (AAG) levels in healthy and pregnant beagle dogs. Exp Anim 2003;52:377–381.
-
21. Kuribayashi T, Shimada T, Matsumoto M, et al. Determination of serum C-reactive protein in healthy Beagle dogs of various ages and pregnant Beagle dogs. Exp Anim 2003;52:387–390.
-
22. Shida T, Kuribayashi T, Seita T, et al. Characteristics of C-reactive protein (CRP), α-1 acid glycoprotein (AAG) and serum amyloid A (SAA) in dogs and cats with malignant cancer. Intern J Appl Res Vet Med 2011;9:376–381.
-
23. Martínez-Subiela S, Ginel PJ, Céron JJ. Effects of different glucocorticoid treatments on serum acute phase proteins in dogs. Vet Rec 2004;154:814–817.
Advertisement
Serum α-1 acid glycoprotein and serum amyloid A concentrations in cats receiving antineoplastic treatment for lymphoma
Abstract
OBJECTIVE To characterize serum α-1 acid glycoprotein (AGP) and serum amyloid A (SAA) concentrations at diagnosis and during treatment in cats with lymphoma.
ANIMALS 16 cats with various anatomic forms of lymphoma and 25 healthy cats.
PROCEDURES Blood samples were collected from healthy cats once and from cats with lymphoma at diagnosis and 2-week intervals until the 12th week of antineoplastic treatment. Serum harvested from blood samples was assessed for AGP and SAA concentrations. Differences in serum AGP and SAA values were investigated between healthy cats and cats with lymphoma (at diagnosis) and, for cats with lymphoma, between diagnosis and various points during treatment.
RESULTS Serum AGP and SAA concentrations were higher in cats with lymphoma at diagnosis (median, 832.60 and 1.03 μg/mL, respectively), compared with those in healthy cats (median, 269.85 and 0.10 μg/mL). Treatment resulted in a gradual decrease in serum AGP concentration after 4 weeks and in SAA concentration after 8 weeks of treatment, and these concentrations returned to values comparable with those of healthy cats by 12 weeks of treatment, by which point all cats had achieved complete remission of the disease.
CONCLUSIONS AND CLINICAL RELEVANCE Serum AGP and SAA concentrations in cats with lymphoma were higher at diagnosis than after antineoplastic treatment. Decreases to values established for healthy cats corresponded with achievement of complete disease remission. Serum AGP and SAA may be useful protein markers for monitoring of antineoplastic treatment in cats with lymphoma.
Contributor Notes
Powered by PubFactory